David Sinclair
Professional Overview
David Sinclair is a renowned co-founder and researcher with extensive experience in the life sciences industry. His expertise spans across multiple facets, including scientific research, entrepreneurship, and strategic advisory roles. Sinclair's work focuses on advancing the frontiers of longevity and rejuvenation, leveraging his deep understanding of the biological mechanisms underlying aging.
Experience Summary
Current Roles
Researcher at University (1999-08-01 to Present)
Sinclair currently serves as a researcher at a prestigious university, where he leads a team of scientists in groundbreaking investigations on the science of aging. In this role, he conducts cutting-edge research, publishes in high-impact scientific journals, and collaborates with industry partners to translate research findings into real-world applications.
Board Member, Investor, Advisor at Life Biosciences (2017-07-01 to Present)
Sinclair is a key board member, investor, and advisor at Life Biosciences, a leading life sciences company focused on developing innovative solutions to combat age-related diseases. In this capacity, he provides strategic guidance, leverages his scientific expertise, and supports the company's mission to improve human health and longevity.
Co-Founder at Fully Aligned Co, LLC (2022-06-01 to Present)
As the co-founder of Fully Aligned Co, LLC, Sinclair is actively involved in developing novel therapeutic approaches and technologies aimed at promoting healthy aging and rejuvenation. He plays a pivotal role in driving the company's research and development efforts, as well as its strategic partnerships and commercialization initiatives.
Co-Founder at EdenRoc Sciences, LLC (2012-06-01 to Present)
Sinclair co-founded EdenRoc Sciences, LLC, a pioneering life sciences company that focuses on advancing the understanding and application of longevity science. In this role, he is responsible for shaping the company's research agenda, forging strategic alliances, and guiding the development of groundbreaking products and services.
Co-founder, Board Member, Scientific Advisor, Investor at Metrobiotech (2013-06-01 to Present)
Sinclair is a co-founder, board member, scientific advisor, and investor at Metrobiotech, a biotechnology company dedicated to developing innovative solutions for age-related diseases. He leverages his extensive scientific knowledge and industry connections to drive the company's research initiatives and ensure the translation of cutting-edge discoveries into viable therapies.
Career Progression
Prior to his current roles, Sinclair held various positions in the life sciences industry, including research roles at leading academic institutions and advisory positions at prominent biotechnology companies. His early career experiences laid the foundation for his deep understanding of the aging process and the development of regenerative therapies.
Academic Background
Sinclair holds a Ph.D. in Molecular Genetics from Harvard University, where he specialized in the study of longevity and the underlying mechanisms of aging. His groundbreaking research and publications have earned him recognition as a leading expert in the field of longevity science.
Areas of Expertise
- Longevity and rejuvenation science
- Molecular genetics and cell biology
- Translational research and product development
- Strategic advisory and entrepreneurship
- Scientific leadership and collaboration
Professional Impact
Sinclair's work has had a significant impact on the life sciences industry, as evidenced by his numerous scientific publications, patents, and industry collaborations. He has been instrumental in driving the development of novel therapeutic approaches, fostering interdisciplinary research, and shaping the future of age-related disease treatment and prevention.
Conclusion
David Sinclair's career trajectory reflects his unwavering commitment to advancing the frontiers of longevity science and transforming the way we approach aging and age-related diseases. As a co-founder, researcher, and strategic advisor, he continues to push the boundaries of scientific understanding and drive the development of innovative solutions that have the potential to improve human health and longevity.
